nevirapine has been researched along with Syndrome in 9 studies
Nevirapine: A potent, non-nucleoside reverse transcriptase inhibitor used in combination with nucleoside analogues for treatment of HIV INFECTIONS and AIDS.
nevirapine : A dipyridodiazepine that is 5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepine which is substituted by methyl, oxo, and cyclopropyl groups at positions 4, 6, and 11, respectively. A non-nucleoside reverse transcriptase inhibitor with activity against HIV-1, it is used in combination with other antiretrovirals for the treatment of HIV infection.
Syndrome: A characteristic symptom complex.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Drug rash with eosinophilia and systemic symptoms (DRESS Syndrome) associated with nevirapine treatment has not been previously reported in children." | 7.74 | Nevirapine-associated rash with eosinophilia and systemic symptoms in a child with human immunodeficiency virus infection. ( Barton, T; Ramilo, O; Santos, RP, 2007) |
| " We report the case of a pregnant human immunodeficiency virus type 1-infected woman who developed drug rash with eosinophilia and systemic symptoms syndrome and renal failure shortly after initiation of a nevirapine-containing antiretroviral regimen at 27 weeks' gestation." | 7.72 | Drug rash with eosinophilia and systemic symptoms syndrome and renal toxicity with a nevirapine-containing regimen in a pregnant patient with human immunodeficiency virus. ( Boswell, H; Fan-Havard, P; Knudtson, E; Para, M, 2003) |
| "Drug rash with eosinophilia and systemic symptoms (DRESS Syndrome) associated with nevirapine treatment has not been previously reported in children." | 3.74 | Nevirapine-associated rash with eosinophilia and systemic symptoms in a child with human immunodeficiency virus infection. ( Barton, T; Ramilo, O; Santos, RP, 2007) |
| " We report the case of a pregnant human immunodeficiency virus type 1-infected woman who developed drug rash with eosinophilia and systemic symptoms syndrome and renal failure shortly after initiation of a nevirapine-containing antiretroviral regimen at 27 weeks' gestation." | 3.72 | Drug rash with eosinophilia and systemic symptoms syndrome and renal toxicity with a nevirapine-containing regimen in a pregnant patient with human immunodeficiency virus. ( Boswell, H; Fan-Havard, P; Knudtson, E; Para, M, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 6 (66.67) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bayonne Kombo, ES | 1 |
| Gathse, A | 1 |
| Kochar, R | 1 |
| Nevah, MI | 1 |
| Lukens, FJ | 1 |
| Fallon, MB | 1 |
| Machicao, VI | 1 |
| Bonnet, F | 1 |
| Lawson-Ayayi, S | 1 |
| Thiébaut, R | 1 |
| Ramanampamonjy, R | 1 |
| Lacoste, D | 1 |
| Bernard, N | 1 |
| Malvy, D | 1 |
| Bonarek, M | 1 |
| Djossou, F | 1 |
| Beylot, J | 1 |
| Dabis, F | 1 |
| Morlat, P | 1 |
| Knudtson, E | 1 |
| Para, M | 1 |
| Boswell, H | 1 |
| Fan-Havard, P | 1 |
| Daniel, OJ | 1 |
| Krain, AB | 1 |
| Ogun, SA | 1 |
| Odusoga, OL | 1 |
| Boyle, BA | 1 |
| Santos, RP | 1 |
| Ramilo, O | 1 |
| Barton, T | 1 |
| MartÃnez, E | 1 |
| Gatell, JM | 1 |
| Lanzafame, M | 1 |
| Rovere, P | 1 |
| De Checchi, G | 1 |
| Trevenzoli, M | 1 |
| Turazzini, M | 1 |
| Parrinello, A | 1 |
| Claudio, GA | 1 |
| Martin, AF | 1 |
| de Dios Perrino, S | 1 |
| Velasco, AA | 1 |
9 other studies available for nevirapine and Syndrome
| Article | Year |
|---|---|
[Tenofovir hypersensitivity to tenofovir (DRESS) syndrome in a female patient infected by HIV].
Topics: Adenine; Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Asthenia; Benzoxazi | 2013 |
Vanishing bile duct syndrome in human immunodeficiency virus: nevirapine hepatotoxicity revisited.
Topics: Adult; Anti-HIV Agents; Bile Duct Diseases; Bile Ducts, Intrahepatic; Cholestasis, Intrahepatic; Fem | 2010 |
A cohort study of nevirapine tolerance in clinical practice: French Aquitaine Cohort, 1997-1999.
Topics: Adult; Alanine Transaminase; Anti-HIV Agents; Cholesterol; Cohort Studies; Female; France; HIV Infec | 2002 |
Drug rash with eosinophilia and systemic symptoms syndrome and renal toxicity with a nevirapine-containing regimen in a pregnant patient with human immunodeficiency virus.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Chemical and Drug Induced Liver Injur | 2003 |
Nevirapine-related adverse events in a patient receiving a fixed-drug combination pill.
Topics: Adult; Anti-HIV Agents; Drug Combinations; Exanthema; Female; HIV Infections; Humans; Nevirapine; Re | 2005 |
Nevirapine-associated rash with eosinophilia and systemic symptoms in a child with human immunodeficiency virus infection.
Topics: Anti-HIV Agents; Child; Drug Hypersensitivity; Eosinophilia; Exanthema; Female; HIV Infections; HIV- | 2007 |
[Lipodystrophy and antiretroviral agents].
Topics: Acquired Immunodeficiency Syndrome; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; HIV Prote | 1999 |
Hypersensitivity syndrome (DRESS) and meningoencephalitis associated with nevirapine therapy.
Topics: Adult; Anti-HIV Agents; Drug Eruptions; Drug Hypersensitivity; Eosinophilia; Exanthema; HIV Infectio | 2001 |
DRESS syndrome associated with nevirapine therapy.
Topics: Adult; Anti-HIV Agents; Drug Eruptions; Drug Monitoring; Eosinophilia; Fever; Humans; Liver Function | 2001 |